See more : Talanx AG (TLLXY) Income Statement Analysis – Financial Results
Complete financial analysis of Kali, Inc. (KALY) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Kali, Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- ADA Société Anonyme (ALADA.PA) Income Statement Analysis – Financial Results
- Buriram Sugar Public Company Limited (BRR.BK) Income Statement Analysis – Financial Results
- Royal Bank of Canada (RY) Income Statement Analysis – Financial Results
- WonderFi Technologies Inc. (WONDF) Income Statement Analysis – Financial Results
- Zevra Therapeutics, Inc. (ZVRA) Income Statement Analysis – Financial Results
Kali, Inc. (KALY)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.kali-extracts.com
About Kali, Inc.
Kali, Inc., doing business as Kali-Extracts, Inc., engages in the research and development of cannabis treatments for various illnesses, diseases, and chronic pain as a symptom of various diagnoses. It provides pharmaceuticals, cannabis extracts, and health and wellness products. The company was formerly known as VLOV Inc. and changed its name to Kali, Inc. in February 2016. Kali, Inc. is based in Dallas, Texas.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 65.27K | 67.59K | 71.54K | 83.62K | 94.55M | 88.83M | 73.83M | 64.34M | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 50.90K | 48.95K | 70.19K | 0.00 | 52.49M | 50.06M | 43.86M | 41.08M | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 14.36K | 18.64K | 1.35K | 83.62K | 42.06M | 38.76M | 29.97M | 23.26M | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 22.01% | 27.58% | 1.89% | 100.00% | 44.48% | 43.64% | 40.59% | 36.15% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 6.27M | 5.47M | 4.06M | 5.09M | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 11.65M | 15.62M | 8.57M | 4.60M | 0.00 | 0.00 | 0.00 |
| SG&A | 0.00 | 0.00 | 0.00 | 0.00 | 26.27K | 27.95K | 0.00 | 88.75K | 17.91M | 21.09M | 12.62M | 9.69M | 66.05K | 65.31K | 10.59K |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -3.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 26.27K | 27.95K | -3.00 | 88.75K | 17.91M | 21.09M | 12.62M | 9.69M | 66.05K | 65.46K | 10.59K |
| Cost & Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 77.17K | 76.90K | 70.19K | 88.75K | 70.40M | 71.15M | 56.49M | 50.77M | 66.05K | 65.46K | 10.59K |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 89.00K | 75.00K | 81.00K | 31.00K | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 8.00K | 67.00K | 58.00K | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 228.49K | 236.56K | 206.30K | 171.86K | 0.00 | 0.00 | 0.00 | 0.00 | 975.00K | 1.67M | 71.00K | 90.00K | 0.00 | 0.00 | 0.00 |
| EBITDA | 0.00 | 0.00 | 0.00 | 0.00 | -11.90K | -9.31K | 1.35K | -5.13K | 25.88M | 20.06M | 19.85M | 14.70M | -66.05K | -65.46K | -10.59K |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | -18.23% | -13.77% | 1.89% | -6.14% | 26.66% | 21.87% | 23.70% | 21.28% | 0.00% | 0.00% | 0.00% |
| Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | -11.90K | -9.31K | 1.35K | -5.13K | 24.14M | 17.68M | 17.35M | 13.57M | -66.05K | -65.46K | -10.59K |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | -18.23% | -13.77% | 1.89% | -6.14% | 25.54% | 19.90% | 23.49% | 21.09% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 0.00 | 0.00 | 0.00 | 0.00 | -3.00 | 0.00 | 0.00 | 0.00 | 762.00K | 706.00K | 2.37M | 982.00K | 0.00 | -912.00 | -1.00 |
| Income Before Tax | 0.00 | 0.00 | 0.00 | 0.00 | -11.90K | -9.31K | 1.35K | -5.13K | 24.91M | 18.38M | 19.71M | 14.55M | -66.05K | -66.37K | -10.59K |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | -18.24% | -13.77% | 1.89% | -6.14% | 26.34% | 20.70% | 26.70% | 22.61% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 7.03M | 4.46M | 4.73M | 4.11M | 0.00 | 0.00 | 0.00 |
| Net Income | 0.00 | 0.00 | 0.00 | 0.00 | -11.90K | -9.31K | 1.35K | -5.13K | 17.52M | 13.48M | 13.41M | 10.45M | -66.05K | -66.37K | -10.59K |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | -18.24% | -13.77% | 1.89% | -6.14% | 18.53% | 15.17% | 18.17% | 16.23% | 0.00% | 0.00% | 0.00% |
| EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 6.83 | 5.42 | 5.79 | 4.93 | -4.44 | -4.90 | -0.79 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 6.78 | 5.36 | 5.79 | 4.91 | -4.44 | -4.90 | -0.79 |
| Weighted Avg Shares Out | 0.00 | 0.00 | 0.00 | 0.00 | 1.02B | 587.24M | 285.13M | 13.85M | 2.57M | 2.49M | 2.32M | 2.12M | 14.88K | 13.55K | 13.33K |
| Weighted Avg Shares Out (Dil) | 0.00 | 0.00 | 0.00 | 0.00 | 1.02B | 587.24M | 285.13M | 13.85M | 2.64M | 2.60M | 2.60M | 2.13M | 14.88K | 13.55K | 13.33K |
Source: https://incomestatements.info
Category: Stock Reports